Brewin Dolphin Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Brewin Dolphin Wealth Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$19K	Hold	55	–	–	﹤0.01%	242
2022 Q1	$30K	Hold	55	–	–	﹤0.01%	226
2021 Q4	$36K	Hold	55	–	–	﹤0.01%	218
2021 Q3	$34.2K	Hold	55	–	–	﹤0.01%	225
2021 Q2	$34.7K	Buy	55 +10	+22%	+$5.52K	﹤0.01%	227
2021 Q1	$22K	Buy	+45	New	+$22.5K	﹤0.01%	248
2020 Q3	–	Sell	-79	Closed	-$26.1K	–	300
2020 Q2	$26.1K	Hold	79	–	–	0.01%	195
2020 Q1	$19.1K	Buy	+79	New	+$20.6K	0.01%	147

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Brewin Dolphin Wealth Management's IDXX Position: Q2 2022 in Review

Brewin Dolphin Wealth Management held its Idexx Laboratories (IDXX) position steady in Q2 2022 at 55 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #242.

Brewin Dolphin Wealth Management first reported a position in IDXX in Q1 2020 and has held it in 8 quarters since. The position peaked at $36K in Q4 2021. 956 funds tracked by Wall St. Rank hold IDXX as of Q2 2022.

Brewin Dolphin Wealth Management held 55 shares of Idexx Laboratories worth $19K as of Q2 2022.
Brewin Dolphin Wealth Management left its Idexx Laboratories share count unchanged in Q2 2022.
Idexx Laboratories made up ﹤0.01% of Brewin Dolphin Wealth Management's portfolio in Q2 2022, its #242 holding.
Brewin Dolphin Wealth Management first reported a position in Idexx Laboratories in Q1 2020 and has held it in 8 quarters since.
Brewin Dolphin Wealth Management's Idexx Laboratories position peaked at $36K in Q4 2021.
956 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2022.

Based on Brewin Dolphin Wealth Management's 13F filing for Q2 2022, filed 14 Nov 2022.